Thrombolex™
@ThrombolexTM
Followers
71
Following
0
Media
405
Statuses
412
Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters used in interventional procedures.
New Britain, PA
Joined February 2021
Today we honor the courage, sacrifice, and service of all veterans. Thrombolex is grateful for the dedication of those who have served our country and for the freedoms they have protected. https://t.co/qqejtgx4Cy
#Thrombolex #VeteransDay
0
0
1
In this clip, Dr. Ayman Iskander discusses how the BASHIR™ Endovascular Catheter enhances clinical impact by restoring blood flow quickly and safely, helping patients recover quickly while optimizing hospital resources. https://t.co/qqejtgx4Cy
#Thrombolex
0
0
1
Join us at TCT 2025 on Oct 26 at 12:04 pm in Innovation Session 3. Dr. Wissam Jaber will present an interim data analysis from the RAPID-PE Study, evaluating on-the-table PML with the BASHIR™ Endovascular Catheter without post-procedural infusion.
0
1
0
Join Thrombolex at TCT 2025 on Oct 26 as Dr. Wissam Jaber presents an interim data analysis of the RAPID-PE Study, a multi-center, prospective study evaluating on-the-table PML with the BASHIR™ Endovascular Catheter without post-procedural infusion. https://t.co/qqejtgx4Cy
0
1
1
Today is World Thrombosis Day. Thrombolex reaffirms our commitment to raising awareness about the serious impact of blood clots. Our focus remains on providing safe, effective Endovascular Catheter solutions for the treatment of thromboembolic disease. https://t.co/lgTcGx8J0T
0
0
0
Methodist Stone Oak Hospital in San Antonio has completed its first PE case using the BASHIR™ Endovascular Catheter, becoming the first HCA hospital in the U.S. to adopt this therapy. Congratulations to Dr. Liu and the team for this milestone in patient care.
0
1
0
The BASHIR™ Endovascular Catheter is engineered to enhance precision & efficacy when treating acute PE, while minimizing complications. A dual-action expandable infusion basket mechanically fissures the thrombus while delivering targeted thrombolytic therapy.
0
0
2
Thank you to PERT 2025 for an inspiring event. Thrombolex is proud to contribute to the advancement of pulmonary embolism treatment and grateful for the chance to connect with leaders in the field, share insights, and help shape the future of patient care.
0
1
0
At Thrombolex, we define innovation by its impact on patient care. For those with acute PE, that means advancing therapies that lead to efficient therapy delivery, less medication, and improved clinical outcomes. Less time. Lower dose. Better Outcomes.
0
0
1
This week, join us for an insightful Breakfast Satellite Session during PERT 2025 where Dr. Ken Rosenfield, Dr. Vivian Bishay, Dr. Wissam Jaber, and Dr. Soophia Naydenov will examine how a breakthrough on-the-table PE therapy is re-writing the health economics story. #Thrombolex
0
0
1
Join Thrombolex at PERT 2025 on September 18 for an insightful Satellite Session: Learn how a breakthrough on-the table PE therapy is re-writing the health economics story. #Thrombolex
https://t.co/qqejtgx4Cy
0
0
1
Join us later this month for PERT 2025. Discover how single-session pharmaco-mechanical lysis (PML) therapy with the BASHIR™ Endovascular Catheter can safely and effectively treat PE. https://t.co/qqejtgx4Cy
#Thrombolex #PERT2025
0
0
0
Today, we pause to remember the lives lost on 9/11 and honor the courage of the first responders who put others before themselves. Their bravery and sacrifice will never be forgotten. May we continue to work toward a future rooted in unity, compassion, and peace.
0
0
0
Thrombolex is proud to be a Gold Sponsor of PERT 2025 and we look forward to sharing how our breakthrough on-the-table Pulmonary Embolism treatment is advancing patient outcomes while driving greater efficiency in health economics. #Thrombolex #PERT2025
0
1
0
The BASHIR™ Endovascular Catheter is a clinically proven, single-session solution for the treatment of acute PE. Its proprietary dual-action design mechanically fissures the thrombus while delivering targeted low-dose thrombolytics.
0
1
0
Watch as Dr. Barry Bertolet discusses how the low-profile BASHIR™ Endovascular Catheter offers a more efficient therapy by enabling smaller venous access and reducing access site complications.
0
1
1
The RESCUE-II Study, recently published in JACC: Advances, evaluated the safety and feasibility of single-session PML using the BASHIR™ Endovascular Catheter. No post-procedural infusion required and no major bleeding events. https://t.co/Pmo3o57Eux
0
0
0
New in JVIR: The BASHIR™ Endovascular Catheter was used in parallel for multicatheter thrombolysis in two complex TIPS cases for acute portomesenteric thrombosis. Read more: https://t.co/9b1hw5UWvI
0
1
0